Table 3.
Incidence Rates and Hazard Ratios of Coronavirus Disease 2019 Diagnosis and Hospitalization Among Recombinant Zoster Vaccinated (≥1 Dose) Versus Unvaccinated Individuals, Among a Subset of Individuals Who Received Influenza Vaccination but no Other Vaccinations in the Year Prior to 1 March 2020
| Outcome | Vaccinated (n = 37 513) | Unvaccinated (n = 75 026) | Hazard Ratio (95% CI) | |||||
|---|---|---|---|---|---|---|---|---|
| No. of Cases | No. of PY | Incidence per 1000 PY (95% CI) | No. of Cases | No. of PY | Incidence per 1000 PY (95% CI) | Unadjusted | Adjusteda | |
| COVID-19 diagnosis | 1356 | 30 677.70 | 44.20 (41.91–46.62) | 3070 | 59 409.98 | 51.67 (49.88–53.54) | 0.84 (.79–.90) | 0.83 (.78–.89) |
| COVID-19 hospitalization | 290 | 30 850.43 | 9.40 (8.38–10.55) | 816 | 59 765.63 | 13.65 (12.75–14.62) | 0.68 (.59–.78) | 0.68 (.59–.78) |
Abbreviations: CI, confidence interval; COVID-19, coronavirus disease 2019; PY, person-years.
Adjusted for covariates: body mass index, smoking, number of outpatient visits, and hypertension.